Screener
Fulgent Genetics, Inc. FLGT Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Fulgent Genetics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026.
- Filed
- May 1, 2026, 7:08 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-199065
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| (Benefit from) provision for income taxes | (704) | 176 |
| Net loss from consolidated operations | (25,274) | (11,899) |
| Net loss attributable to noncontrolling interests | 448 | 369 |
| Net loss attributable to Fulgent | $(24,826) | $(11,530) |
| Net loss per common share attributable to Fulgent | ||
| Basic | $(0.80) | $(0.37) |
| Diluted | $(0.80) | $(0.37) |
| Weighted-average common shares: |
Item 1. Financial Statements.
FAQ
- What is Fulgent Genetics, Inc.'s net income?
- Fulgent Genetics, Inc. (FLGT) reported net income of -$24.83M in Q1 2026.
- How has Fulgent Genetics, Inc.'s net income changed year-over-year?
- Fulgent Genetics, Inc.'s net income decreased by 115.3% year-over-year, from -$11.53M to -$24.83M.
- What is the long-term trend for Fulgent Genetics, Inc.'s net income?
- Over 4 years (2021 to 2025), Fulgent Genetics, Inc.'s net income has grown at a -41.2% compound annual growth rate (CAGR), from $507.36M to -$60.51M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.
Ask your AI about Fulgent Genetics, Inc.'s net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude